Department of Medicine, University of California, San Francisco, CA, USA.
Endocrine Research Unit, San Francisco Veterans Affairs Health Care System, San Francisco, CA, USA.
J Bone Miner Res. 2017 Nov;32(11):2239-2247. doi: 10.1002/jbmr.3212. Epub 2017 Aug 9.
Bone marrow fat is a unique fat depot that may regulate bone metabolism. Marrow fat is increased in states of low bone mass, severe underweight, and diabetes. However, longitudinal effects of weight loss and improved glucose homeostasis on marrow fat are unclear, as is the relationship between marrow fat and bone mineral density (BMD) changes. We hypothesized that after Roux-en-Y gastric bypass (RYGB) surgery, marrow fat changes are associated with BMD loss. We enrolled 30 obese women, stratified by diabetes status. Before and 6 months after RYGB, we measured BMD by dual-energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT) and vertebral marrow fat content by magnetic resonance spectroscopy. At baseline, those with higher marrow fat had lower BMD. Postoperatively, total body fat declined dramatically in all participants. Effects of RYGB on marrow fat differed by diabetes status (p = 0.03). Nondiabetic women showed no significant mean change in marrow fat (+1.8%, 95% confidence interval [CI] -1.8% to +5.4%, p = 0.29), although those who lost more total body fat were more likely to have marrow fat increases (r = -0.70, p = 0.01). In contrast, diabetic women demonstrated a mean marrow fat change of -6.5% (95% CI -13.1% to 0%, p = 0.05). Overall, those with greater improvements in hemoglobin A1c had decreases in marrow fat (r = 0.50, p = 0.01). Increases in IGF-1, a potential mediator of the marrow fat-bone relationship, were associated with marrow fat declines (r = -0.40, p = 0.05). Spinal volumetric BMD decreased by 6.4% ± 5.9% (p < 0.01), and femoral neck areal BMD decreased by 4.3% ± 4.1% (p < 0.01). Marrow fat and BMD changes were negatively associated, such that those with marrow fat increases had more BMD loss at both spine (r = -0.58, p < 0.01) and femoral neck (r = -0.49, p = 0.01), independent of age and menopause. Our findings suggest that glucose metabolism and weight loss may influence marrow fat behavior, and marrow fat may be a determinant of bone metabolism. © 2017 American Society for Bone and Mineral Research.
骨髓脂肪是一种独特的脂肪库,可能调节骨代谢。在低骨量、严重体重不足和糖尿病状态下,骨髓脂肪增加。然而,减肥和改善葡萄糖稳态对骨髓脂肪的纵向影响尚不清楚,骨髓脂肪与骨密度(BMD)变化之间的关系也是如此。我们假设 Roux-en-Y 胃旁路(RYGB)手术后,骨髓脂肪的变化与 BMD 丢失有关。我们招募了 30 名肥胖女性,并按糖尿病状态进行分层。在 RYGB 手术前和 6 个月后,我们通过双能 X 射线吸收法(DXA)和定量计算机断层扫描(QCT)测量 BMD,并通过磁共振波谱测量椎体骨髓脂肪含量。在基线时,骨髓脂肪含量较高的患者 BMD 较低。术后,所有参与者的全身脂肪量均显著下降。RYGB 对骨髓脂肪的影响因糖尿病状态而异(p=0.03)。非糖尿病女性的骨髓脂肪无显著平均变化(+1.8%,95%置信区间[CI] -1.8%至+5.4%,p=0.29),尽管那些全身脂肪减少更多的女性更有可能增加骨髓脂肪(r=-0.70,p=0.01)。相比之下,糖尿病女性的骨髓脂肪平均变化为-6.5%(95%CI -13.1%至 0%,p=0.05)。总体而言,血红蛋白 A1c 改善更大的患者骨髓脂肪减少(r=0.50,p=0.01)。胰岛素样生长因子 1(IGF-1)的增加,骨髓脂肪与骨关系的潜在介质,与骨髓脂肪的下降有关(r=-0.40,p=0.05)。脊柱容积 BMD 下降 6.4%±5.9%(p<0.01),股骨颈面积 BMD 下降 4.3%±4.1%(p<0.01)。骨髓脂肪和 BMD 的变化呈负相关,即骨髓脂肪增加的患者在脊柱(r=-0.58,p<0.01)和股骨颈(r=-0.49,p=0.01)的 BMD 丢失更多,独立于年龄和绝经状态。我们的研究结果表明,葡萄糖代谢和体重减轻可能影响骨髓脂肪的行为,骨髓脂肪可能是骨代谢的决定因素。